Neuropace, Inc. NPCE Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s debt issuance cost amortization?
- Neuropace, Inc. (NPCE) reported debt issuance cost amortization of $68K in Q1 2026.
- How has Neuropace, Inc.'s debt issuance cost amortization changed year-over-year?
- Neuropace, Inc.'s debt issuance cost amortization increased by 38.8% year-over-year, from $49K to $68K.
- What is the long-term trend for Neuropace, Inc.'s debt issuance cost amortization?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s debt issuance cost amortization has grown at a -2.9% compound annual growth rate (CAGR), from $267K to $237K.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).